Jiajing Dai published a dataset on figshare in 2026. The data likely contains measurements of VCAM1 expression in glioma stem cell-like cells and tumor microenvironment-associated astrocytes from mouse models, correlated with patient survival outcomes from clinical datasets. The file is 4.4 KB in size.
Use Cases
- Correlate VCAM1 expression levels with patient survival based on clinical data mentioned in the description
- Analyze co-expression patterns of VCAM1 with markers like SOX2, CD133, and Ki67 based on glioma model data
- Compare VCAM1 expression in different tumor locations and genetic backgrounds based on mouse model results
- Evaluate the therapeutic potential of targeting VCAM1 signaling based on survival benefit data
Strengths
- Includes specific co-expression percentages (e.g., 86.5% of SOX2+ cells) from a glioma model
- Contains survival data with concrete median survival times (e.g., 52 to 66.5 days) from mouse models
- Correlates findings with clinical patient survival outcomes mentioned in the description
Limitations
- Row count is unknown, which may limit suitability assessment
- Column-level documentation is absent; field semantics must be inferred after download
- The dataset is very small (4.4 KB), indicating limited scope
Provenance
- Source
- figshare
- Collection Method
- Likely derived from experimental mouse glioma models and analysis of human glioma datasets.
- Freshness
- Last updated 2026-04-24 04:23:05; freshness should be verified